Jade Share Price

Jade Share Price

NASDAQ: JBIO | Small Cap | Healthcare
$15.30
+$0.25 (1.66%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • About
  • Price history
  • FAQs

Jade Stock Performance

Open
$15.35
Prev. Close
$15.05
Circuit Range
N/A
Day Range
$15.20 - $15.50
Year Range
$11.47 - $27.70
Volume
64,031
Average Traded
$15.34

Jade Share Price Today

As of 22 November 2026, Jade Biosciences, Inc.'s share price is $15.30. The stock opened at $15.35, compared to its previous close of $15.05. During today's trading session, Jade Biosciences, Inc.'s share price traded between $15.20 and $15.50, with an average price of $15.35. Over the past 52 weeks, the stock has recorded a high of $27.70 and a low of $11.47. In terms of performance, Jade Biosciences, Inc.'s share price has declined by 27.38% over the last six months and is up 19.02% on a year-on-year basis.

Jade Share Price Chart

Line chart of the Jade price trend over the selected period. The price rose overall, ranging from 15.01 to 15.52, ending at 15.31.
$15.20$15.50
L
Show Current Price
H

Jade Stock Fundamentals & Key Indicators

Market Cap
$479.81M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.85
Revenue (TTM)
N/A
Return On Equity (TTM)
-28.15%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-56.16%

Jade Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$19.09-$33.13-$46.21-$29.81
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-73.55%-39.48%35.49%

Jade Balance Sheet

All figures in USD Million

Particulars2025
Non Current Assets0.97
Current Assets348.82
Total Assets349.78
Non Current Liabilities0.72
Current Liabilities16.54
Total Liabilities17.26
Shareholders' Equity332.52

About Jade

Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.

Jade Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$14.35
$15.31
+8.89%
Oct 2026
$13.85
$14.06
-0.07%
Sep 2026
$21.55
$14.07
-33.97%
Aug 2026
$19.57
$21.32
+7.90%
Jul 2026
$22.30
$19.75
-11.01%
Jun 2026
$20.55
$22.20
+5.36%
May 2026
$24.01
$21.07
-13.59%
Apr 2026
$14.19
$24.39
+73.87%
Mar 2026
$14.81
$14.03
-5.36%
Feb 2026
$16.48
$14.82
-4.91%
Jan 2026
$15.31
$15.59
+1.27%
Dec 2025
$12.46
$15.39
+19.72%

Jade Share Price FAQs